Ganta Roman R, Cheng Chuanmin, Wilkerson Melinda J, Chapes Stephen K
Department of Diagnostic Medicine/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, Kansas 66506, USA.
Infect Immun. 2004 Jan;72(1):159-67. doi: 10.1128/IAI.72.1.159-167.2004.
Human monocytic ehrlichiosis is an emerging tick-borne disease caused by the rickettsia Ehrlichia chaffeensis. To examine the role of helper T cells in host resistance to this macrophage-tropic bacterium, we assessed E. chaffeensis infections in three mouse strains with differing functional levels of helper T cells. Wild-type, C57BL/6J mice resolved infections in approximately 2 weeks. Major histocompatibility complex class II (MHCII) knockout, B6.129-Abb(tm1) mice lacking helper T cells developed persistent infections that were not resolved even after several months. CD4+ T-cell-deficient, B6.129S6-Cd4(tm1Knw) mice cleared the infection, but the clearance took 2 weeks longer than it did for wild-type mice. C57BL/6J mice resolved infection more rapidly following a second experimental challenge, but B6.129S6-Cd4(tm1Knw) mice did not. The B6.129S6-Cd4(tm1Knw) mice also developed active E. chaffeensis-specific immunoglobulin G responses that were slightly lower in concentration and slower to develop than that observed in C57BL/6J mice. E. chaffeensis-specific cytotoxic T cells were not detected following a single bacterial challenge in any mouse strain, including wild-type C57BL/6J mice. However, the cytotoxic T-cell activity developed in all three mouse strains, including the MHCII and CD4+ T-cell knockouts, when challenged with a second E. chaffeensis infection. The data reported here suggest that the cell-mediated immunity, orchestrated by CD4+ T cells is critical for conferring rapid clearance of E. chaffeensis.
人单核细胞埃立克体病是一种由立克次氏体查菲埃立克体引起的新出现的蜱传疾病。为了研究辅助性T细胞在宿主抵抗这种嗜巨噬细胞细菌中的作用,我们评估了三种辅助性T细胞功能水平不同的小鼠品系对查菲埃立克体的感染情况。野生型C57BL/6J小鼠在大约2周内清除感染。主要组织相容性复合体II类(MHCII)基因敲除的、缺乏辅助性T细胞的B6.129-Abb(tm1)小鼠发生持续性感染,即使数月后也未清除。CD4+ T细胞缺陷的B6.129S6-Cd4(tm1Knw)小鼠清除了感染,但清除时间比野生型小鼠长2周。C57BL/6J小鼠在第二次实验性攻击后能更快地清除感染,但B6.129S6-Cd4(tm1Knw)小鼠则不能。B6.129S6-Cd4(tm1Knw)小鼠也产生了活跃的查菲埃立克体特异性免疫球蛋白G反应,其浓度略低于C57BL/6J小鼠,且产生速度较慢。在任何小鼠品系中,包括野生型C57BL/6J小鼠,单次细菌攻击后均未检测到查菲埃立克体特异性细胞毒性T细胞。然而,当用第二次查菲埃立克体感染进行攻击时,所有三种小鼠品系,包括MHCII和CD4+ T细胞敲除品系,均产生了细胞毒性T细胞活性。此处报告的数据表明,由CD4+ T细胞协调的细胞介导免疫对于快速清除查菲埃立克体至关重要。